Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Men with erectile dysfunction may be able to turn to Medtronic Inc.’s (NYSE:MDT) drug-eluting pudendal stent when drugs fail to help.
Abbott’s (NYSE:ABT) plan to spinout its pharmaceuticals division met with a lukewarm response from investors and mixed views on whether other pharma firms will bid for the new firm.